Development of a nomogram predicting perineural invasion risk and assessment of the prognostic value of perineural invasion in colon cancer: a population study based on the Surveillance, Epidemiology, and End Results database.

IF 1.5 4区 医学 Q4 ONCOLOGY Translational cancer research Pub Date : 2025-01-31 Epub Date: 2025-01-23 DOI:10.21037/tcr-24-1030
Zhongqiang Zheng, Xuanzi Sun
{"title":"Development of a nomogram predicting perineural invasion risk and assessment of the prognostic value of perineural invasion in colon cancer: a population study based on the Surveillance, Epidemiology, and End Results database.","authors":"Zhongqiang Zheng, Xuanzi Sun","doi":"10.21037/tcr-24-1030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Perineural invasion (PNI) in colon cancer (CC) is widely associated with poor prognosis. In this study, we aimed to develop a predictive model for PNI and to assess its prognostic value in CC patients.</p><p><strong>Methods: </strong>Data for CC patients with or without PNI were obtained from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015. Potential features were selected by stepwise logistic regression, and multivariate logistic regression was used to develop the nomogram. Nomogram performance was assessed based on its calibration curve, discrimination ability and clinical utility. The prognostic value of PNI was assessed using Kaplan-Meier analysis, a competing risk model, and a Fine-Gray multivariable regression model.</p><p><strong>Results: </strong>A total of 51,826 subjects were included in the study. The nomogram consisted of 11 features was constructed, which provided good calibration and discrimination with area under the curve values of 0.787 <i>vs.</i> 0.781 (development cohort <i>vs.</i> validation cohort). Patients with PNI had worse CC-specific survival (P<0.001) and a higher CC-specific death rate (Gray's test, P<0.001) than patients without PNI. Fine-Gray multivariable regression analysis showed that patients with PNI had a higher CC-specific death rate than patients without PNI [hazard ratio (HR) =1.243; 95% confidence interval (CI): 1.183-1.305; P<0.001]. Pathologic stage T4 (pT4) CC patients without PNI treated with chemotherapy (ChemT) plus radiotherapy (RT) had a lower CC-specific death rate than ChemT-treated or non-therapy patients.</p><p><strong>Conclusions: </strong>The nomogram developed herein has certain clinical application value for predicting PNI risk in CC patients. PNI is a survival predictor for CC patients. pT4 patients without PNI might benefit from combined ChemT and RT.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 1","pages":"141-158"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833362/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-1030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Perineural invasion (PNI) in colon cancer (CC) is widely associated with poor prognosis. In this study, we aimed to develop a predictive model for PNI and to assess its prognostic value in CC patients.

Methods: Data for CC patients with or without PNI were obtained from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015. Potential features were selected by stepwise logistic regression, and multivariate logistic regression was used to develop the nomogram. Nomogram performance was assessed based on its calibration curve, discrimination ability and clinical utility. The prognostic value of PNI was assessed using Kaplan-Meier analysis, a competing risk model, and a Fine-Gray multivariable regression model.

Results: A total of 51,826 subjects were included in the study. The nomogram consisted of 11 features was constructed, which provided good calibration and discrimination with area under the curve values of 0.787 vs. 0.781 (development cohort vs. validation cohort). Patients with PNI had worse CC-specific survival (P<0.001) and a higher CC-specific death rate (Gray's test, P<0.001) than patients without PNI. Fine-Gray multivariable regression analysis showed that patients with PNI had a higher CC-specific death rate than patients without PNI [hazard ratio (HR) =1.243; 95% confidence interval (CI): 1.183-1.305; P<0.001]. Pathologic stage T4 (pT4) CC patients without PNI treated with chemotherapy (ChemT) plus radiotherapy (RT) had a lower CC-specific death rate than ChemT-treated or non-therapy patients.

Conclusions: The nomogram developed herein has certain clinical application value for predicting PNI risk in CC patients. PNI is a survival predictor for CC patients. pT4 patients without PNI might benefit from combined ChemT and RT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
期刊最新文献
Exploration of key pathogenic mechanisms and potential intervention targets of the traditional Chinese medicine Coptis chinensis in the treatment of cervical cancer based on network pharmacology and molecular docking techniques. FTO-mediated m6A demethylation of SERPINE1 mRNA promotes tumor progression in hypopharyngeal squamous cell carcinoma. How to select between osimertinib or afatinib in P-loop and αC-helix compressing (G719X, S768I) or classical-like (L861Q) EGFR mutations: what preclinical models and clinical data have taught us in the early 2020s. Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma. Immune checkpoint inhibitors plus paclitaxel-based chemotherapy vs. oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1